SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: biowa who wrote (1670)11/16/1999 1:36:00 PM
From: arnie h  Read Replies (2) | Respond to of 2173
 
Biowa:
The PR had to do with results of the type 1 trial.
The type 2 results announced previously had a reduction of 0.7 along with the weight change advantage and an improved ldl/hdl ratio.
Arnie